Investors
We maintain a transparent, comprehensive dialogue with the financial community about our strategy, outlook, financial data, economic environment, and social impact.
Second Quarter 2025
Second quarter 2025 results were reviewed by management during a live audio webcast with the financial community on July 31, 2025. The presentation was followed by a Q&A session.
Press Releases
September 17, 2025
Press Release: EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study
September 11, 2025
Press Release: Sanofi’s SAR402663 earns fast track designation in the US for neovascular age-related macular degeneration
September 10, 2025
Media Update: ECTRIMS: Sanofi showcases patient focus across multiple sclerosis
Upcoming Events
23Sep
2025
25Sep
2025
Baader Investment Conference
Conferences
30th Consecutive Year of Dividend Increase
Environment, Social, Governance
As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.
Contact Our Investor Relations Team
For general inquiries
Please contact the switchboard, +33 (0)1 53 77 40 00